New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

An integrated strategy for the prevention, support and treatment of prostate cancer was launched today. The plan, which was ...

Cases of prostate cancer are on the rise in California, according to new research. A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the national average. This rise spans across all age groups, ethnicities ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

It affects about 2% of the population and is mediated ... Alarming Rise in Rates of Advanced Prostate Cancer in California Feb. 3, 2025 — The incidence of advanced prostate cancer in California ...